Prescription Drugs
US Congress 116th Congress
Short on Competition Act [S.844]
A bill to allow for expedited approval of generic prescription drugs and temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages.
Spread the world
Gettr US Congress 116th Congress
Warrior Wellness Act [HB-1801]
Warrior Wellness Act directs the Department of Defense (DOD) to report to congressional committees on its shortage of mental health providers and include a strategy to better recruit and retain mental health providers. DOD must report on the practices for prescribing medication during a specified period that were inconsistent with the post-traumatic stress disorder medication guidelines developed by DOD and the Veterans Health Administration (VHA). The Departments of the Army, Navy, and Air Force must each establish a monitoring program to (1) periodically
(continued...)
Spread the world
US Congress 116th Congress
A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. [S.801]
Allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Spread the world
US Congress 116th Congress
Cancer Drug Parity Act of 2019 [HB-1730]
Requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase
(continued...)
Spread the world
US Congress 116th Congress
Cancer Drug Parity Act of 2019 [S.741]
Requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase
(continued...)
Spread the world
US Congress 116th Congress
John S. McCain Opioid Addiction Prevention Act [S.724]
Establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV. Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
Spread the world
US Congress 116th Congress
John S. McCain Opioid Addiction Prevention Act [HB-1614]
Establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV. Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
Spread the world
US Congress 116th Congress
Medicare Extra Rx HELP Act of 2019 Medicare Extra Rx Higher Eligibility Limits in Part D Act of 2019 [S.691]
Expands eligibility for certain premium subsidies for low-income beneficiaries under the Medicare prescription drug benefit. Specifically, the bill raises the maximum allowable income for beneficiaries to qualify from 135% to 200% of the federal poverty line.
Spread the world
US Congress 116th Congress
Prescription Drug Pricing Dashboard Act [S.709]
Requires the Department of Health and Human Services to establish an online dashboard containing information about the prices and utilization of prescription drugs that are purchased by federal programs. The dashboard must include specified information, including spending per dosage, the number of drug recipients, and out-of-pocket costs. The dashboard must also highlight those drugs that have the highest spending and costs.
Spread the world
US Congress 116th Congress
Fairness to Pet Owners Act of 2019 [HB-1607]
Directs the Federal Trade Commission to require a prescriber of a household-animal medication to provide a free copy of the prescription to the pet owner without the pet owner having the request a copy.
Spread the world
US Congress 116th Congress
340B Protection and Accountability Act of 2019 [HB-1559]
To amend the Public Health Service Act to strengthen program integrity and enhance low-income patient benefits for safety net providers.
Spread the world
US Congress 116th Congress
Orange Book Transparency Act of 2019 [HB-1503]
To amend the Federal Food, Drug, and Cosmetic Act regarding the list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, and for other purposes.
Spread the world
US Congress 116th Congress
A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits. [S.657]
Prohibits health insurers and contracted entities that provide pharmacy benefits management services from receiving a price reduction or other remuneration from prescription drug manufacturers. The prohibition does not apply if (1) the price reduction is reflected at the point-of-sale; and (2) the other remuneration is a transparent, flat service fee that the manufacturer pays in relation to pharmacy benefits management services.
Spread the world
US Congress 116th Congress
Protecting Consumer Access to Generic Drugs Act of 2019 [HB-1499]
To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.
Spread the world
US Congress 116th Congress
FAIR Generics Act Fair And Immediate Release of Generic Drugs Act [HB-1506]
To amend the Federal Food, Drug, and Cosmetic Act to ensure that valid generic drugs may enter the market.
Spread the world
US Congress 116th Congress
ADAPT Act Accelerated Drug Approval for Prescription Therapies Act [S.658]
A bill to provide for an accelerated approval pathway for certain drugs that are authorized to be lawfully marketed in other countries.
Spread the world
US Congress 116th Congress
Treat and Reduce Obesity Act of 2019 [HB-1530]
Expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner. The bill also allows coverage under Medicare's prescription
(continued...)
Spread the world
US Congress 116th Congress
Phair Pricing Act of 2019 [S.640]
Requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale. Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager. Additionally, the Centers for Medicare & Medicaid Services must establish certain quality measures for PDP sponsors
(continued...)
Spread the world
US Congress 116th Congress
Affordable Insulin Act of 2019 [HB-1478]
To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe insulin by wholesale distributors, pharmacies, and individuals.
Spread the world
US Congress 116th Congress
Affordable Insulin Act of 2019 [HB-1478]
To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe insulin by wholesale distributors, pharmacies, and individuals.